TODEXAL 3 mg/1 mg per ml, eye drop suspension bottle, 5 ml
Active ingredients: Dexamethasone, Tobramycin
Commercialized according to BDPMDispensing in France: Prescription only
Eye drop suspensionbottle, 5 mlophtalmique
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- TODEXAL 3 mg/1 mg par ml, collyre en suspension
- Pharmaceutical form
- collyre en suspension
- Route of administration
- ophtalmique
- Presentation description
- 1 flacon compte-gouttes polyéthylène basse densité (PEBD) de 5 ml
- Marketing authorisation holder
- LABORATOIRES DOLIAGE DEVELOPPEMENT
- Reimbursement according to BDPM
- 30 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 9 Nov 2020
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66581684CIP73015150CIP133400930151501Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| DEXAMÉTHASONEcollyre | 1 mg · 1 mL de collyre en suspension | SA |
| TOBRAMYCINEcollyre | 3 mg · 1 mL de collyre en suspension | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.